Add a listing
0
Add a listing

Eliem’s stock slides 20% after saying it will discontinue development of pain treatment

44712 eliems stock slides 20 after saying it will discontinue development of pain treatment

Shares of Eliem Therapeutics Inc. ELYM, -12.58% tumbled 20.0% in premarket trading on Tuesday after the company said it will discontinue development of its treatment for lumbosacral radicular pain after a Phase 2a clinical trial didn’t yield strong enough results. Eliem said it has enough capital to fund the development of other therapies and its operations through mid-2024. Eliem’s stock is down 70.9% this year, while the S&P 500 SPX, +0.13% has declined 14.5%.

Source: Marketwatch

Related Posts

Recent Posts
Leading Key
Asian Shares Asian Stocks bafin Blog brent brokerswatch CBI Ireland cftc cointelegraph Commodities Crude Oil energy european fca fcnb FINRA Forex fsma fxpro Gold gold-price Inflation Interview Market Analysis markets Marketwatch News News stories oil oott OPEC Press Release Press Releases Roboforex Russia Speech Statements stock markets Stocks Technical analysis tickmill Trading Warning Notice wti xgloabalmarkets
About
brokerswatch white red logo
Searching for the right forex broker is no easy task, but have no fear! Brokerswatch.com has made it very simple.  Find the right brokers based on the criteria most important to you and compare them side by side for easier selection
Twitter Facebook-f Instagram Linkedin Reddit

Brokers By Regulator

Forex Brokers List

Trading Tools

Risk Warning: FX trading is high risk and may not be suitable for all investors. Leverage will create additional risks and loss. Before trading, please carefully consider your investment goals, experience and risk tolerance levels. Loss of  part or all of your initial investment is possible;  therefore do not invest money that you cannot afford to lose. It is advised to educate yourself about FX trading before you trade real money. Disclaimer:  All data and information on this Website are provided “as is” and to be used only for information purposes.  Information is not  intended for trading or trading recommendations.  The operators of this website shall not be liable for any loss incurred by you as a result of reliance on the information contained in the Website.